4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000005
Chief Medical Officer sold 49,638 shares at an average $50.08 ($2,485,989)
- Chief Medical Officer acquired 43,973 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bowden Christopher · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-04 | Exercise or conversion : show line 1 in the form | +8,526 | $35.16 | $299,774 | 15,841 | D |
| 2020-02-04 | Sale : show line 2 in the form | −14,191 | $50.03 | $709,963 | 1,650 | D |
| 2020-02-05 | Exercise or conversion : show line 3 in the form | +35,447 | $35.16 | $1,246,317 | 37,097 | D |
| 2020-02-04 | Sale : show line 4 in the form | −35,447 | $50.10 | $1,776,026 | 1,650 | D |
| Open-market sales · 49,638 sh · avg $50.08 · $2,485,989 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-04 | Exercise or conversion : show line 5 in the form Stock option (right to buy) | −8,526 | 62,474 | D |
| 2020-02-05 | Exercise or conversion : show line 6 in the form Stock option (right to buy) | −35,447 | 27,027 | D |
Loading xslF345X03/wf-form4_158102593034853.xml…